F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 64 filers reported holding F-STAR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 21.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $334,966 | +23.6% | 53,001 | 0.0% | 0.23% | +14.6% |
| Q3 2022 | $271,000 | -18.4% | 53,001 | 0.0% | 0.20% | -11.9% |
| Q2 2022 | $332,000 | +76.6% | 53,001 | 0.0% | 0.23% | +105.5% |
| Q1 2022 | $188,000 | -29.3% | 53,001 | 0.0% | 0.11% | -26.2% |
| Q4 2021 | $266,000 | -31.4% | 53,001 | 0.0% | 0.15% | -53.3% |
| Q3 2021 | $388,000 | -14.7% | 53,001 | 0.0% | 0.32% | -14.2% |
| Q2 2021 | $455,000 | -20.7% | 53,001 | 0.0% | 0.37% | -27.1% |
| Q1 2021 | $574,000 | +9.8% | 53,001 | 0.0% | 0.51% | +6.7% |
| Q4 2020 | $523,000 | – | 53,001 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,834,360 | $9,208,000 | 5.02% |
| DAFNA Capital Management LLC | 693,785 | $3,483,000 | 0.88% |
| Atlas Venture Advisors, Inc. | 574,996 | $2,886,000 | 0.40% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,010,000 | 0.28% |
| Anson Funds Management LP | 309,703 | $1,555,000 | 0.15% |
| Connolly Sarah T. | 53,001 | $266,000 | 0.15% |
| Rock Springs Capital Management LP | 751,889 | $3,774,000 | 0.09% |
| Point72 Asset Management, L.P. | 981,249 | $4,926,000 | 0.02% |
| Eversept Partners, LP | 49,933 | $250,664 | 0.02% |
| Private Capital Advisors, Inc. | 13,083 | $66,000 | 0.01% |